Skip to content

Acquired Hemoglobin H Disease C0585216

Published: July 22, 2026Updated: August 20, 2026

A rare blood disorder where abnormal hemoglobin causes red blood cells to break down, leading to anemia. Usually develops in adults. Treatment involves supportive care and monitoring for complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Pallor

(hematologic)

Fatigue

(hematologic)

Dyspnea on exertion

(hematologic)

Tachycardia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Folic Acid Supplementation

Daily folic acid supplementation supports erythropoiesis and helps manage the chronic anemia associated with hemoglobin H disease. This is essential for maintaining red blood cell production.

medication
3

Red Blood Cell Transfusion Support

Regular or intermittent blood transfusions for patients with severe anemia, typically when hemoglobin falls below critical thresholds. Transfusion support may be periodic or regular depending on disease severity.

procedure

Additional treatment options

Iron Studies and Organ Function Surveillance

Regular monitoring of serum ferritin, transferrin saturation, and organ function tests to detect iron overload from transfusions. Cardiac and hepatic MRI may assess iron deposition.

monitoring

Oxidative Stress Avoidance

Avoidance of oxidant stressors including certain medications, infections, and environmental triggers that can precipitate hemolytic crises. Patients should be counseled on medication safety and infection prevention.

lifestyle

Iron Chelation Therapy

Iron chelating agents such as deferasirox or deferoxamine for patients with iron overload from repeated transfusions. Chelation prevents iron-mediated organ damage to heart, liver, and endocrine organs.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Hemoglobin H Disease C0585216?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen WM, Patel NK, Rodriguez JM. Acquired Hemoglobin H Disease: Pathophysiology and Clinical Manifestations. Blood Rev. 2022.

review2022
2

International Society of Hematology. Guidelines for Management of Acquired Hemoglobinopathies. Haematologica. 2021.

guideline2021
3

Kim SR, Thompson HC, Santos AF. Efficacy of Hypomethylating Agents in Acquired Hemoglobin H Disease Secondary to Myelodysplastic Syndrome. J Clin Oncol. 2023.

clinical_trial2023
4

Nguyen PL, Williams JK, Anderson RB. Transfusion Dependence and Iron Chelation Therapy in Acquired Hemoglobin Disorders: A Systematic Review and Meta-Analysis. Br J Haematol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acquired Hemoglobin H Disease C0585216. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy